Enspryng is the first approved therapy for NMOSD designed to target and inhibit interleukin-6 receptor activity, using novel […]
High SABA inhaler use was associated with around twice the number of exacerbations, the SABINA study found
The survey, by the British Medical Association, highlights the huge challenge in returning to a normal service as […]
Updated Date: Mon, 10 Aug 2020 00:00:00 EDT
Updated Date: Mon, 10 Aug 2020 00:00:00 EDT
Updated Date: Mon, 10 Aug 2020 00:00:00 EDT
Updated Date: Mon, 10 Aug 2020 00:00:00 EDT
Updated Date: Mon, 10 Aug 2020 00:00:00 EDT
Moderna stands to earn $300M for quick vaccine approval, up to $6.6B for extra doses: filing esagonowsky Mon, […]
